Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

12/21/07 MGMT Immunohistochemical Expression and Promoter Methylation in Human Glioblastoma.        

12/21/07 CONVECTION-ENHANCED DELIVERY OF CINTREDEKIN BESUDOTOX (INTERLEUKIN-13-PE38QQR) FOLLOWED BY RADIATION THERAPY WITH AND WITHOUT TEMOZOLOMIDE IN NEWLY DIAGNOSED MALIGNANT GLIOMAS: PHASE 1 STUDY OF FINAL SAFETY RESULTS.        

12/19/07 Positive Phase 2 data from glioma study        

12/19/07 ZFN Modified Cells Show Glioblastoma Killing in the Presence of Dexamethasone in Mouse Tumor Model        

12/19/07 Brain Cancer Drug Looks Very Promising        

12/19/07 Neurognostics: Leading neuroscience centers select Neurognostics fMRI system        

12/19/07 Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.        

12/19/07 Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study.        

12/19/07 Chemotherapy protocol '8 drugs in 1 day' in patients with recurrent malignant glioma        

12/19/07 Atopy and Risk of Brain Tumors: A Meta-analysis        

12/15/07 At last, a decent Tx for deadliest brain tumours        

12/15/07 Radiation for Brain Cancer Reduces Brain Function in Children        

12/11/07 New Image-Guided Radiotherapy System Benefits High-Risk Patients        

12/09/07 Adjuvant chemotherapy for adults with malignant glioma: a systematic review.        

12/09/07 New brain tumor videos on virtualtrials.com        

12/08/07 Combination of Measles Virus Virotherapy and Radiation Therapy Has Synergistic Activity in the Treatment of Glioblastoma Multiforme.        

12/08/07 A phase I trial of lenalidomide in patients with recurrent primary central nervous system tumors.        

12/08/07 Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors.        

12/08/07 A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle.        

---

Displaying Stories 3701 to 3720 of 7673
Previous 20           Next 20